Regenxbio
RGNX
120 hedge funds and large institutions have $668M invested in Regenxbio in 2018 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 41 increasing their positions, 32 reducing their positions, and 16 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
88% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 16
28% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 32
24% more call options, than puts
Call options by funds: $5.03M | Put options by funds: $4.06M
11% more funds holding
Funds holding: 108 → 120 (+12)
1.37% more ownership
Funds ownership: 69.29% → 70.66% (+1.4%)
7% less capital invested
Capital invested by funds: $718M → $668M (-$49.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$20.5M |
| 2 |
RI
RTW Investments
New York
|
+$9.21M |
| 3 |
WM
WS Management
Jacksonville,
Florida
|
+$5.82M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$5.34M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$16.1M |
| 2 |
PA
Perceptive Advisors
New York
|
-$15.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$6M |
| 4 |
AC
Ascend Capital
Orinda,
California
|
-$5.43M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.16M |
RGNX Hedge Fund Activity: Q1 2018 in Review
120 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q1 2018, worth a combined $668M — down 7% from $718M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new RGNX positions and 16 closed out — a net gain of 14 holders — while 41 added to existing stakes and 32 trimmed.
The largest buyer was Redmile Group, adding an estimated $20.5M. The largest seller was GMT Capital, exiting entirely with an estimated $16.1M sold.
- 120 institutional investors held Regenxbio (RGNX) as of Q1 2018, up from 108 in Q4 2017.
- Funds reported $668M of Regenxbio stock for Q1 2018, down 7% quarter-over-quarter.
- 30 funds opened new Regenxbio positions in Q1 2018 and 16 closed out, a net change of +14 holders.
- The largest Regenxbio buyer in Q1 2018 was Redmile Group, an estimated $20.5M added.
- The largest Regenxbio seller in Q1 2018 was GMT Capital, an estimated $16.1M sold.
Based on aggregated 13F filings for Q1 2018.